Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 20 de 641
Filtrer
1.
Microbiol Spectr ; 12(6): e0042723, 2024 Jun 04.
Article de Anglais | MEDLINE | ID: mdl-38695573

RÉSUMÉ

Escherichia coli O157:H7 is a globally important foodborne pathogen with implications for food safety. Antibiotic treatment for O157 may potentially contribute to the exacerbation of hemolytic uremic syndrome, and the increasing prevalence of antibiotic-resistant strains necessitates the development of new treatment strategies. In this study, the bactericidal effects and resistance development of antibiotic and bacteriophage monotherapy were compared with those of combination therapy against O157. Experiments involving continuous exposure of O157 to phages and antibiotics, along with genetic deletion studies, revealed that the deletion of glpT and uhpT significantly increased resistance to fosfomycin. Furthermore, we found that OmpC functions as a receptor for the PP01 phage, which infects O157, and FhuA functions as a receptor for the newly isolated SP15 phage, targeting O157. In the glpT and uhpT deletion mutants, additional deletion in ompC, the receptor for the PP01 phage, increased resistance to fosfomycin. These findings suggest that specific phages may contribute to antibiotic resistance by selecting the emergence of gene mutations responsible for both phage and antibiotic resistance. While combination therapy with phages and antibiotics holds promise for the treatment of bacterial infections, careful consideration of phage selection is necessary.IMPORTANCEThe combination treatment of fosfomycin and bacteriophages against Escherichia coli O157 demonstrated superior bactericidal efficacy compared to monotherapy, effectively suppressing the emergence of resistance. However, mutations selected by phage PP01 led to enhanced resistance not only to the phage but also to fosfomycin. These findings underscore the importance of exercising caution in selecting phages for combination therapy, as resistance selected by specific phages may increase the risk of developing antibiotic resistance.


Sujet(s)
Antibactériens , Infections à Escherichia coli , Escherichia coli O157 , Fosfomycine , Antibactériens/pharmacologie , Escherichia coli O157/virologie , Escherichia coli O157/effets des médicaments et des substances chimiques , Escherichia coli O157/génétique , Infections à Escherichia coli/microbiologie , Infections à Escherichia coli/traitement médicamenteux , Humains , Fosfomycine/pharmacologie , Résistance bactérienne aux médicaments , Bactériophages/génétique , Bactériophages/physiologie , Bactériophages/effets des médicaments et des substances chimiques , Phagothérapie/méthodes , Coliphages/génétique , Coliphages/effets des médicaments et des substances chimiques , Coliphages/physiologie , Protéines Escherichia coli/génétique , Protéines Escherichia coli/métabolisme
2.
Chemosphere ; 361: 142421, 2024 Aug.
Article de Anglais | MEDLINE | ID: mdl-38797202

RÉSUMÉ

Research has demonstrated the presence of viruses in wastewater (WW), which can remain viable for a long period, posing potential health risks. Conventional WW treatment methods involving UV light, chlorine and ozone efficiently reduce microbial concentrations, however, they produce hazardous byproducts and microbial resistance that are detrimental to human health and the ecosystem. Hence, there is a need for novel disinfection techniques. Antimicrobial Photodynamic Inactivation (PDI) emerges as a promising strategy, utilizing photosensitizers (PS), light, and dioxygen to inactivate viruses. This study aims to assess the efficacy of PDI by testing methylene blue (MB) and the cationic porphyrin TMPyP as PSs, along a low energy consuming white light source (LED) at an irradiance of 50 mW/cm2, for the inactivation of bacteriophage Phi6. Phi6 serves as an enveloped RNA-viruses surrogate model in WW. PDI experiments were conducted in a buffer solution (PBS) and real WW matrices (filtered and non-filtered). Considering the environmental release of the treated effluents, this research also evaluated the ecotoxicity of the resulting solution (post-PDI treatment effluent) on the model organism Daphnia magna, following the Organisation for Economic Cooperation and Development (OECD) immobilization technical 202 guideline. Daphnids were exposed to WW containing the tested PS at different concentrations and dilutions (accounting for the dilution factor during WW release into receiving waters) over 48 h. The results indicate that PDI with MB efficiently inactivated the model virus in the different aqueous matrices, achieving reductions superior to 8 log10 PFU/mL, after treatments of 5 min in PBS and of ca. 90 min in WW. Daphnids survival increased when subjected to the PDI-treated WW with MB, considering the dilution factor. Overall, the effectiveness of PDI in eliminating viruses in WW, the fading of the toxic effects on daphnids after MB' irradiation and the rapid dilution effect upon WW release in the environment highlight the possibility of using MB in WW PDI-disinfection.


Sujet(s)
Daphnia , Désinfection , Bleu de méthylène , Photosensibilisants , Eaux usées , Eaux usées/composition chimique , Désinfection/méthodes , Daphnia/effets des médicaments et des substances chimiques , Photosensibilisants/pharmacologie , Photosensibilisants/composition chimique , Animaux , Bleu de méthylène/pharmacologie , Bleu de méthylène/composition chimique , Porphyrines/composition chimique , Porphyrines/pharmacologie , Bactériophages/effets des médicaments et des substances chimiques , Élimination des déchets liquides/méthodes , Purification de l'eau/méthodes , Écotoxicologie
3.
mBio ; 15(6): e0050424, 2024 Jun 12.
Article de Anglais | MEDLINE | ID: mdl-38757974

RÉSUMÉ

A recent demonstration of synergy between a temperate phage and the antibiotic ciprofloxacin suggested a scalable approach to exploiting temperate phages in therapy, termed temperate phage-antibiotic synergy, which specifically interacted with the lysis-lysogeny decision. To determine whether this would hold true across antibiotics, we challenged Escherichia coli with the phage HK97 and a set of 13 antibiotics spanning seven classes. As expected, given the conserved induction pathway, we observed synergy with classes of drugs known to induce an SOS response: a sulfa drug, other quinolones, and mitomycin C. While some ß-lactams exhibited synergy, this appeared to be traditional phage-antibiotic synergy, with no effect on the lysis-lysogeny decision. Curiously, we observed a potent synergy with antibiotics not known to induce the SOS response: protein synthesis inhibitors gentamicin, kanamycin, tetracycline, and azithromycin. The synergy results in an eightfold reduction in the effective minimum inhibitory concentration of gentamicin, complete eradication of the bacteria, and, when administered at sub-optimal doses, drastically decreases the frequency of lysogens emerging from the combined challenge. However, lysogens exhibit no increased sensitivity to the antibiotic; synergy was maintained in the absence of RecA; and the antibiotic reduced the initial frequency of lysogeny rather than selecting against formed lysogens. Our results confirm that SOS-inducing antibiotics broadly result in temperate-phage-specific synergy, but that other antibiotics can interact with temperate phages specifically and result in synergy. This is the first report of a means of chemically blocking entry into lysogeny, providing a new means for manipulating the key lysis-lysogeny decision.IMPORTANCEThe lysis-lysogeny decision is made by most bacterial viruses (bacteriophages, phages), determining whether to kill their host or go dormant within it. With over half of the bacteria containing phages waiting to wake, this is one of the most important behaviors in all of biology. These phages are also considered unusable for therapy because of this behavior. In this paper, we show that many antibiotics bias this behavior to "wake" the dormant phages, forcing them to kill their host, but some also prevent dormancy in the first place. These will be important tools to study this critical decision point and may enable the therapeutic use of these phages.


Sujet(s)
Antibactériens , Escherichia coli , Lysogénie , Antibactériens/pharmacologie , Escherichia coli/virologie , Escherichia coli/effets des médicaments et des substances chimiques , 19351/effets des médicaments et des substances chimiques , Tests de sensibilité microbienne , Coliphages/physiologie , Coliphages/effets des médicaments et des substances chimiques , Synergie des médicaments , Bactériophages/physiologie , Bactériophages/effets des médicaments et des substances chimiques , Mitomycine/pharmacologie
4.
Int J Surg ; 110(9): 5374-5384, 2024 Sep 01.
Article de Anglais | MEDLINE | ID: mdl-38742847

RÉSUMÉ

BACKGROUND: With the antibiotic crisis, the topical antibacterial control including chronic wounds gains increasing importance. However, little is known regarding tolerance development when bacteria face repetitive exposure to the identical antiseptics as commonly found in clinical practice. MATERIALS AND METHODS: Clinical isolates foremost of chronic wounds were exposed in vitro to dilutions of two antiseptics used for wound therapy: polyhexanide or octenidine. Adaptive response was determined by growth/kill curves, minimal inhibitory concentration (MIC), and whole genome sequencing. Antiseptic/bacteriophage combinations were studied by liquid-infection assays and bacterial plating. RESULTS: Polyhexanide acted stronger against Escherichia coli and Proteus mirabilis while octenidine was more potent against Staphylococcus aureus . Otherwise, the antiseptic efficacy varied across isolates of Klebsiella pneumoniae , Pseudomonas aeruginosa , and Acinetobacter baumannii . Upon repetitive exposure with constant antiseptic concentrations P. aeruginosa and P. mirabilis adaptation was evident by a reduced lag-phase and a twofold increased MIC. Under increasing octenidine concentrations, P. aeruginosa adapted to an eightfold higher dosage with mutations in smvA , opgH , and kinB affecting an efflux pump, alginate and biofilm formation, respectively. S. aureus adapted to a fourfold increase of polyhexanide with a mutation in the multiple peptide resistance factor MprF, also conferring cross-resistance to daptomycin. Antiseptic/bacteriophage combinations enhanced bacterial inhibition and delayed adaptation. CONCLUSION: Different bacterial species/strains respond unequally to low-level antiseptic concentrations. Bacterial adaptation potential at phenotypic and genotypic levels may indicate the necessity for a more nuanced selection of antiseptics. Bacteriophages represent a promising yet underexplored strategy for supporting antiseptic treatment, which may be particularly beneficial for the management of critical wounds.


Sujet(s)
Anti-infectieux locaux , Biguanides , Imines , Pyridines , Anti-infectieux locaux/pharmacologie , Anti-infectieux locaux/administration et posologie , Biguanides/pharmacologie , Humains , Pyridines/pharmacologie , Pyridines/administration et posologie , Bactériophages/effets des médicaments et des substances chimiques , Tests de sensibilité microbienne , Pseudomonas aeruginosa/effets des médicaments et des substances chimiques , Infection de plaie/microbiologie , Infection de plaie/traitement médicamenteux , Staphylococcus aureus/effets des médicaments et des substances chimiques , Acinetobacter baumannii/effets des médicaments et des substances chimiques , Plaies et blessures/microbiologie , Plaies et blessures/traitement médicamenteux , Escherichia coli/effets des médicaments et des substances chimiques
5.
Environ Res ; 252(Pt 2): 118921, 2024 Jul 01.
Article de Anglais | MEDLINE | ID: mdl-38631474

RÉSUMÉ

Bacteriophages (phages) are viruses capable of regulating the proliferation of antibiotic resistant bacteria (ARB). However, phages that directly cause host lethality may quickly select for phage resistant bacteria, and the co-evolutionary trade-offs under varying environmental conditions, including the presence of antibiotics, remains unclear as to their impact on phage and antibiotic resistance. Here, we report the emergence of phage resistance in three distinct E. coli strains with varying resistance to ß-lactam antibiotics, treated with different ampicillin (AMP) concentrations. Hosts exhibiting stronger antibiotic resistance demonstrated a higher propensity to develop and maintain stable phage resistance. When exposed to polyvalent phage KNT-1, the growth of AMP-sensitive E. coli K12 was nearly suppressed within 18 h, while the exponential growth of AMP-resistant E. coli TEM and super-resistant E. coli NDM-1 was delayed by 12 h and 8 h, respectively. The mutation frequency and mutated colony count of E. coli NDM-1 were almost unaffected by co-existing AMP, whereas for E. coli TEM and K12, these metrics significantly decreased with increasing AMP concentration from 8 to 50 µg/mL, becoming unquantifiable at 100 µg/mL. Furthermore, the fitness costs of phage resistance mutation and its impact on initial antibiotic resistance in bacteria were further examined, through analyzing AMP susceptibility, biofilm formation and EPS secretion of the isolated phage resistant mutants. The results indicated that acquiring phage resistance could decrease antibiotic resistance, particularly for hosts lacking strong antibiotic resistance. The ability of mutants to form biofilm contributes to antibiotic resistance, but the correlation is not entirely positive, while the secretion of extracellular polymeric substance (EPS), especially the protein content, plays a crucial role in protecting the bacteria from both antibiotic and phage exposure. This study explores phage resistance development in hosts with different antibiotic resistance and helps to understand the limitations and possible solutions of phage-based technologies.


Sujet(s)
Antibactériens , Bactériophages , Escherichia coli , Antibactériens/pharmacologie , Escherichia coli/effets des médicaments et des substances chimiques , Escherichia coli/virologie , Bactériophages/physiologie , Bactériophages/effets des médicaments et des substances chimiques , Résistance bactérienne aux médicaments/génétique , Ampicilline/pharmacologie
6.
J Appl Microbiol ; 134(8)2023 Aug 01.
Article de Anglais | MEDLINE | ID: mdl-37580171

RÉSUMÉ

AIMS: To provide an alternative to ultra violet light and vapourized hydrogen peroxide to enhance decontamination of surfaces as part of the response to the COVID-19 pandemic. METHODS AND RESULTS: We developed an indirect method for in situ delivery of cold plasma and evaluated the anti-viral activity of plasma-activated mist (PAM) using bacteriophages phi6, MS2, and phiX174, surrogates for SARS-CoV-2. Exposure to ambient air atmospheric pressure derived PAM caused a 1.71 log10 PFU ml-1 reduction in phi6 titer within 5 min and a 7.4 log10 PFU ml-1 reduction after 10 min when the the PAM source was at 5 and 10 cm. With MS2 and phiX174, a 3.1 and 1.26 log10 PFU ml-1 reduction was achieved, respectively, after 30 min. The rate of killing was increased with longer exposure times but decreased when the PAM source was further away. Trace amounts of reactive species, hydrogen peroxide and nitrite were produced in the PAM, and the anti-viral activity was probably attributable to these and their secondary reactive species. CONCLUSIONS: PAM exhibits virucidal activity against surrogate viruses for COVID-19, which is time and distance from the plasma source dependent.


Sujet(s)
Bactériophages , Désinfection , Peroxyde d'hydrogène , Nitrites , Gaz plasmas , Bactériophages/effets des médicaments et des substances chimiques , Bactériophages/physiologie , COVID-19/virologie , Désinfectants/composition chimique , Désinfection/méthodes , Peroxyde d'hydrogène/pharmacologie , Nitrites/pharmacologie , Gaz plasmas/pharmacologie , Espèces réactives de l'azote/analyse , Espèces réactives de l'oxygène/analyse , SARS-CoV-2/physiologie , Eau/composition chimique , Microbiologie de l'air
7.
ACS Appl Mater Interfaces ; 13(41): 48469-48477, 2021 Oct 20.
Article de Anglais | MEDLINE | ID: mdl-34623127

RÉSUMÉ

The COVID-19 pandemic highlighted the importance of developing surfaces and coatings with antiviral activity. Here, we present, for the first time, peptide-based assemblies that can kill viruses. The minimal inhibitory concentration (MIC) of the assemblies is in the range tens of micrograms per milliliter. This value is 2 orders of magnitude smaller than the MIC of metal nanoparticles. When applied on a surface, by drop casting, the peptide spherical assemblies adhere to the surface and form an antiviral coating against both RNA- and DNA-based viruses including coronavirus. Our results show that the coating reduced the number of T4 bacteriophages (DNA-based virus) by 3 log, compared with an untreated surface and 6 log, when compared with a stock solution. Importantly, we showed that this coating completely inactivated canine coronavirus (RNA-based virus). This peptide-based coating can be useful wherever sterile surfaces are needed to reduce the risk of viral transmission.


Sujet(s)
Antiviraux/composition chimique , Peptides/composition chimique , Animaux , Antiviraux/pharmacologie , Antiviraux/usage thérapeutique , Bactériophages/effets des médicaments et des substances chimiques , COVID-19/virologie , Coronavirus/effets des médicaments et des substances chimiques , Coronavirus/isolement et purification , Infections à coronavirus/traitement médicamenteux , Infections à coronavirus/virologie , Dopa/composition chimique , Maladies des chiens/traitement médicamenteux , Maladies des chiens/virologie , Chiens , Humains , Nanoparticules métalliques/composition chimique , Peptides/pharmacologie , Peptides/usage thérapeutique , SARS-CoV-2/isolement et purification , Inactivation virale/effets des médicaments et des substances chimiques , Traitements médicamenteux de la COVID-19
8.
Viruses ; 13(5)2021 05 10.
Article de Anglais | MEDLINE | ID: mdl-34068736

RÉSUMÉ

Deoxyuridine in DNA has recently been in the focus of research due to its intriguing roles in several physiological and pathophysiological situations. Although not an orthodox DNA base, uracil may appear in DNA via either cytosine deamination or thymine-replacing incorporations. Since these alterations may induce mutation or may perturb DNA-protein interactions, free living organisms from bacteria to human contain several pathways to counteract uracilation. These efficient and highly specific repair routes uracil-directed excision repair initiated by representative of uracil-DNA glycosylase families. Interestingly, some bacteriophages exist with thymine-lacking uracil-DNA genome. A detailed understanding of the strategy by which such phages can replicate in bacteria where an efficient repair pathway functions for uracil-excision from DNA is expected to reveal novel inhibitors that can also be used for biotechnological applications. Here, we also review the several potential biotechnological applications already implemented based on inhibitors of uracil-excision repair, such as Crispr-base-editing and detection of nascent uracil distribution pattern in complex genomes.


Sujet(s)
ADN viral/composition chimique , ADN viral/génétique , Uracile , Virus/génétique , Bactériophages/effets des médicaments et des substances chimiques , Bactériophages/génétique , Bactériophages/métabolisme , Biotechnologie , ADN viral/métabolisme , Développement de médicament , Humains , Modèles moléculaires , Acides nucléiques/composition chimique , Acides nucléiques/métabolisme , Conformation des protéines , Relation structure-activité , Uracile/composition chimique , Uracil-DNA glycosidase/composition chimique , Uracil-DNA glycosidase/métabolisme , Virus/effets des médicaments et des substances chimiques , Virus/métabolisme
9.
J Hosp Infect ; 112: 108-113, 2021 Jun.
Article de Anglais | MEDLINE | ID: mdl-33864891

RÉSUMÉ

BACKGROUND: The presence of coronaviruses on surfaces in the patient environment is a potential source of indirect transmission. Manual cleaning and disinfection measures do not always achieve sufficient removal of surface contamination. This increases the importance of automated solutions in the context of final disinfection of rooms in the hospital setting. Ozone is a highly effective disinfectant which, combined with high humidity, is an effective agent against respiratory viruses. Current devices allow continuous nebulization for high room humidity as well as ozone production without any consumables. AIM: In the following study, the effectiveness of a fully automatic room decontamination system based on ozone was tested against bacteriophage Φ6 (phi 6) and bovine coronavirus L9, as surrogate viruses for the pandemic coronavirus SARS-CoV-2. METHODS: For this purpose, various surfaces (ceramic tile, stainless steel surface and furniture board) were soiled with the surrogate viruses and placed at two different levels in a gas-tight test room. After using the automatic decontamination device according to the manufacturer's instructions, the surrogate viruses were recovered from the surfaces and examined by quantitative cultures. Then, reduction factors were calculated. FINDINGS: The ozone-based room decontamination device achieved virucidal efficacy (reduction factor >4 log10) against both surrogate organisms regardless of the different surfaces and positions confirming a high activity under the used conditions. CONCLUSION: Ozone is highly active against SARS-CoV-2 surrogate organisms. Further investigations are necessary for a safe application and efficacy in practice as well as integration into routine processes.


Sujet(s)
Automatisation/instrumentation , COVID-19/prévention et contrôle , Désinfectants/pharmacologie , Désinfection/instrumentation , Désinfection/méthodes , Ozone/pharmacologie , Animaux , Bactériophages/effets des médicaments et des substances chimiques , COVID-19/transmission , Bovins , Coronavirus bovin/effets des médicaments et des substances chimiques , Infection croisée/prévention et contrôle , Infection croisée/virologie , Décontamination/instrumentation , Décontamination/méthodes , Équipement et fournitures hospitaliers/virologie , Hôpitaux , Humains , SARS-CoV-2/effets des médicaments et des substances chimiques
10.
Viruses ; 13(3)2021 03 11.
Article de Anglais | MEDLINE | ID: mdl-33799646

RÉSUMÉ

Many bacteria carry bacteriophages (bacterial viruses) integrated in their genomes in the form of prophages, which replicate passively alongside their bacterial host. Environmental conditions can lead to prophage induction; the switching from prophage replication to lytic replication, that results in new bacteriophage progeny and the lysis of the bacterial host. Despite their abundance in the gut, little is known about what could be inducing these prophages. We show that several medications, at concentrations predicted in the gut, lead to prophage induction of bacterial isolates from the human gut. We tested five medication classes (non-steroidal anti-inflammatory, chemotherapy, mild analgesic, cardiac, and antibiotic) for antimicrobial activity against eight prophage-carrying human gut bacterial representative isolates in vitro. Seven out of eight bacteria showed signs of growth inhibition in response to at least one medication. All medications led to growth inhibition of at least one bacterial isolate. Prophage induction was confirmed in half of the treatments showing antimicrobial activity. Unlike antibiotics, host-targeted medications led to a species-specific induction of Clostridium beijerinckii, Bacteroides caccae, and to a lesser extent Bacteroides eggerthii. These results show how common medication consumption can lead to phage-mediated effects, which in turn would alter the human gut microbiome through increased prophage induction.


Sujet(s)
Bactéries/croissance et développement , Bactéries/virologie , Bactériophages/croissance et développement , Lysogénie/effets des médicaments et des substances chimiques , Préparations pharmaceutiques/administration et posologie , Activation virale/effets des médicaments et des substances chimiques , Bactéries/effets des médicaments et des substances chimiques , Bactéries/génétique , Bactériophages/effets des médicaments et des substances chimiques , Microbiome gastro-intestinal/effets des médicaments et des substances chimiques , Humains
11.
Viruses ; 13(3)2021 03 23.
Article de Anglais | MEDLINE | ID: mdl-33807067

RÉSUMÉ

Effective broad-spectrum antiviral treatments are in dire need as disinfectants and therapeutic alternatives. One such method of disinfection is photodynamic inactivation, which involves the production of reactive oxygen species from dissolved oxygen in response to light-stimulated photosensitizers. This study evaluated the efficacy of functionalized porphyrin compounds for photodynamic inactivation of bacteriophages as human virus surrogates. A blue-light light emitting diode (LED) lamp was used to activate porphyrin compounds in aqueous solution (phosphate buffer). The DNA bacteriophages ΦX174 and P22 were more resistant to porphyrin TMPyP photodynamic inactivation than RNA bacteriophage fr, with increasing rates of inactivation in the order: ΦX174 << P22 << fr. Bacteriophage ΦX174 was therefore considered a resistant virus suitable for the evaluation of three additional porphyrins. These porphyrins were synthesized from TMPyP by inclusion of a central palladium ion (PdT4) and/or the addition of a hydrophobic C14 chain (PdC14 or C14). While the inactivation rate of bacteriophage ΦX174 via TMPyP was similar to previous reports of resistant viruses, ΦX174 inactivation increased by a factor of approximately 2.5 using the metalloporphyrins PdT4 and PdC14. The order of porphyrin effectiveness was TMPyP < C14 < PdT4 < PdC14, indicating that both Pd2+ ligation and C14 functionalization aided virus inactivation.


Sujet(s)
Bactériophages/effets des médicaments et des substances chimiques , Désinfection/méthodes , Photosensibilisants/pharmacologie , Porphyrines/composition chimique , Inactivation virale
12.
Gut Microbes ; 13(1): 1-19, 2021.
Article de Anglais | MEDLINE | ID: mdl-33779498

RÉSUMÉ

Oral antibiotics are commonly prescribed to non-hospitalized adults. However, antibiotic-induced changes in the human gut microbiome are often investigated in cohorts with preexisting health conditions and/or concomitant medication, leaving the effects of antibiotics not completely understood. We used a combination of omic approaches to comprehensively assess the effects of antibiotics on the gut microbiota and particularly the gut resistome of a small cohort of healthy adults. We observed that 3 to 19 species per individual proliferated during antibiotic treatment and Gram-negative species expanded significantly in relative abundance. While the overall relative abundance of antibiotic resistance gene homologs did not significantly change, antibiotic-specific gene homologs with presumed resistance toward the administered antibiotics were common in proliferating species and significantly increased in relative abundance. Virome sequencing and plasmid analysis showed an expansion of antibiotic-specific resistance gene homologs even 3 months after antibiotic administration, while paired-end read analysis suggested their dissemination among different species. These results suggest that antibiotic treatment can lead to a persistent expansion of antibiotic resistance genes in the human gut microbiota and provide further data in support of good antibiotic stewardship.Abbreviation: ARG - Antibiotic resistance gene homolog; AsRG - Antibiotic-specific resistance gene homolog; AZY - Azithromycin; CFX - Cefuroxime; CIP - Ciprofloxacin; DOX - Doxycycline; FDR - False discovery rate; GRiD - Growth rate index value; HGT - Horizontal gene transfer; NMDS - Non-metric multidimensional scaling; qPCR - Quantitative polymerase chain reaction; RPM - Reads per million mapped reads; TA - Transcriptional activity; TE - Transposable element; TPM - Transcripts per million mapped reads.


Sujet(s)
Antibactériens/usage thérapeutique , Résistance microbienne aux médicaments , Fèces/microbiologie , Fèces/virologie , Microbiome gastro-intestinal/effets des médicaments et des substances chimiques , Microbiote/effets des médicaments et des substances chimiques , Adolescent , Adulte , Sujet âgé , Bactéries/virologie , Bactériophages/effets des médicaments et des substances chimiques , Guerre biologique , Études de cohortes , Transfert horizontal de gène/effets des médicaments et des substances chimiques , Humains , Métagénome/effets des médicaments et des substances chimiques , Adulte d'âge moyen , Plasmides/effets des médicaments et des substances chimiques , Transcriptome/effets des médicaments et des substances chimiques , Virome/effets des médicaments et des substances chimiques , Jeune adulte
13.
Int J Mol Sci ; 22(4)2021 Feb 09.
Article de Anglais | MEDLINE | ID: mdl-33572073

RÉSUMÉ

The purpose of the study was to obtain an external coating based on nanoparticles of ZnO, carvacrol, and geraniol that could be active against viruses such as SARS-Co-V2. Additionally, the synergistic effect of the chosen substances in coatings was analyzed. The goal of the study was to measure the possible antibacterial activity of the coatings obtained. Testing antiviral activity with human pathogen viruses, such as SARS-Co-V2, requires immense safety measures. Bacteriophages such as phi 6 phage represent good surrogates for the study of airborne viruses. The results of the study indicated that the ZC1 and ZG1 coatings containing an increased amount of geraniol or carvacrol and a very small amount of nanoZnO were found to be active against Gram-positive and Gram-negative bacteria. It is also important that a synergistic effect between these active substances was noted. This explains why polyethylene (PE) films covered with the ZC1 or ZG1 coatings (as internal coatings) were found to be the best packaging materials to extend the quality and freshness of food products. The same coatings may be used as the external coatings with antiviral properties. The ZC1 and ZG1 coatings showed moderate activity against the phi 6 phage that has been selected as a surrogate for viruses such as coronaviruses. It can be assumed that coatings ZG1 and ZC1 will also be active against SARS-CoV-2 that is transmitted via respiratory droplets.


Sujet(s)
Monoterpènes acycliques/composition chimique , Antibactériens/composition chimique , Antiviraux/composition chimique , Cymènes/composition chimique , Nanoparticules métalliques/composition chimique , Oxyde de zinc/composition chimique , Antibactériens/pharmacologie , Antiviraux/pharmacologie , Bactériophages/effets des médicaments et des substances chimiques , COVID-19/anatomopathologie , COVID-19/virologie , Vecteurs de médicaments/composition chimique , Bactéries à Gram négatif/effets des médicaments et des substances chimiques , Bactéries à Gram positif , SARS-CoV-2/effets des médicaments et des substances chimiques , SARS-CoV-2/isolement et purification
14.
Nanotechnology ; 32(20): 205102, 2021 May 14.
Article de Anglais | MEDLINE | ID: mdl-33561842

RÉSUMÉ

This study explored the application of colloidal and immobilized silver nanoparticles (AgNPs) for inactivation of bacteriophages. Coliphages that are commonly used as indicators for enteric viruses, were used in this study. Colloidal AgNPs were synthesized via a chemical reduction approach using sodium borohydride as reducing agent and trisodium citrate as stabilizing agent. AgNP-immobilized glass substrate was prepared by immobilizing AgNPs on amine-functionalized glass substrate by post-immobilization method. The AgNP-immobilized glass substrate was also tested so as to minimize the release of AgNPs in the treated water. The characterization of AgNPs and the AgNP-immobilized glass surface was done using field emission gun-transmission electron microscopy and scanning electron microscopy. Studies conducted with varying concentrations of colloidal AgNPs displayed good antiviral activity for MS2 and T4 bacteriophage. Colloidal AgNPs at a dose of 60 µg ml-1 could completely inactivate MS2 and T4 bacteriophage within 30 and 50 min with an initial concentration of 103 PFU ml-1. Contaminated water (100 ml) in an unstirred batch reactor with an initial bacteriophage concentration of 103 PFU ml-1 could be inactivated by the AgNP-immobilized glass substrate (1 cm × 1 cm, containing 3.7 µg cm-2 silver) suspended centrally in the batch reactor. Complete 3-Log bacteriophage inactivation was achieved within 70 and 80 min for MS2 and T4 bacteriophage, respectively, while the aqueous silver concentration was less than 25 µg l-1. This is significantly lower than the recommended standard for silver in drinking water (i.e. 100 µg l-1, US EPA). Thus, AgNP-immobilized glass may have good potential for generating virus-free drinking water.


Sujet(s)
Antiviraux , Nanoparticules métalliques/composition chimique , Argent , Antiviraux/composition chimique , Antiviraux/pharmacologie , Bactériophages/effets des médicaments et des substances chimiques , Bioréacteurs/microbiologie , Bioréacteurs/virologie , Escherichia coli/virologie , Argent/composition chimique , Argent/pharmacologie , Propriétés de surface
15.
Ecotoxicol Environ Saf ; 207: 111310, 2021 Jan 01.
Article de Anglais | MEDLINE | ID: mdl-32937228

RÉSUMÉ

Antibiotic resistance genes (ARGs) in mariculture sediments pose a potential risk to public health due to their ability to transfer from environmental bacteria to human pathogens. Long term, this may reduce pathogen susceptibility to antibiotics in medical settings. In recent years, the poly-culture of multiple species has become a popular mariculture approach in China, thanks to its environmental and economic benefits. However, differences in microbial communities and antibiotic resistome between mono- and poly-culture systems are still unclear. In this study, microbial community composition and profiles of entire (microbial DNA) and mobile (plasmid and phage) ARGs in prawn mono- and poly-culture systems were investigated using metagenomics. The abundance of several viruses and human pathogens were enhanced in prawn poly-culture ponds, when compared to monoculture systems. In contrast, sediments from poly-culture systems had a lower diversity and ARG abundance when compared to mono-culture approaches. These ARG variations were predominantly related to mobile genetic elements. Prawn mariculture activities exerted a unique selectivity for ARGs in plasmids, and this selectivity was not influenced by culture methods. The findings of this study have important implications for the selection of mariculture systems in preventing pollution with ARGs.


Sujet(s)
Aquaculture , Résistance microbienne aux médicaments/génétique , Microbiote/physiologie , Bactéries/effets des médicaments et des substances chimiques , Bactériophages/effets des médicaments et des substances chimiques , Bactériophages/génétique , Chine , Culture (sociologie) , Gènes bactériens/effets des médicaments et des substances chimiques , Humains , Métagénomique , Microbiote/effets des médicaments et des substances chimiques
16.
Ann N Y Acad Sci ; 1496(1): 23-34, 2021 07.
Article de Anglais | MEDLINE | ID: mdl-33175408

RÉSUMÉ

Antibiotic resistance has reached dangerously high levels throughout the world. A growing number of bacteria pose an urgent, serious, and concerning threat to public health. Few new antibiotics are available to clinicians and only few are in development, highlighting the need for new strategies to overcome the antibiotic resistance crisis. Combining existing antibiotics with phages, viruses the infect bacteria, is an attractive and promising alternative to standalone therapies. Phage-antibiotic combinations have been shown to suppress the emergence of resistance in bacteria, and sometimes even reverse it. Here, we discuss the mechanisms by which phage-antibiotic combinations reduce resistance evolution, and the potential limitations these mechanisms have in steering microbial resistance evolution in a desirable direction. We also emphasize the importance of gaining a better understanding of mechanisms behind physiological and evolutionary phage-antibiotic interactions in complex in-patient environments.


Sujet(s)
Antibactériens/pharmacologie , Bactéries/effets des médicaments et des substances chimiques , Bactériophages/effets des médicaments et des substances chimiques , Résistance microbienne aux médicaments/effets des médicaments et des substances chimiques , Évolution moléculaire , Phagothérapie , Bactéries/génétique , Gènes bactériens
17.
Pak J Biol Sci ; 23(11): 1481-1486, 2020 Jan.
Article de Anglais | MEDLINE | ID: mdl-33274878

RÉSUMÉ

BACKGROUND AND OBJECTIVE: Pectobacterium carotovorum subsp. carotovorum is a plant-pathogenic bacterium. It is a post-harvest pathogen and causes soft rot diseases in infected plants. Different virulent bacteriophages have been isolated from different regions in the world. These bacteriophages were tolerant to high concentrations of calcium chloride and magnesium chloride. Whereas, the high concentrations of zinc chloride and aluminum chloride decreased the activity and stability of phages. Therefore, the present research aimed to study the biology of P. carotovorum phage (Pc1) by using a one-step growth experiment, its stability to different concentrations of some chemicals and molecular characteristics of this phage isolate. MATERIALS AND METHODS: One step growth experiment, chemical stability, and molecular characteristics by using RAPD-PCR of P. carotovorum phage (Pc1) were studied. RESULTS: The P. carotovorum phage (Pc1) isolate was found to have a latent period of 20 min and its burst size is about 92 pfu cell-1. Calcium chloride, magnesium chloride, and copper sulphate (from 0.1-0.5 mM) increased the infectivity of Pc1 phage, while, zinc chloride in the same concentrations reduced its infectivity. RAPD-PCR amplification was indicated that the total amplified products were 32 bands with size ranged from 0.179-2.365 Kbp. CONCLUSION: Since, zinc chloride (at concentrations of 0.1-0.5 mM) reduced infectivity of Pc1 phage isolate, therefore, any chemical compounds containing zinc must be avoided in designing biocontrol strategy by using phages against soft rot bacterium (P. carotovorum) in potatoes.


Sujet(s)
Bactériophages/pathogénicité , Pectobacterium/virologie , Lutte biologique contre les nuisibles , Maladies des plantes/prévention et contrôle , Solanum tuberosum/microbiologie , Bactériophages/effets des médicaments et des substances chimiques , Bactériophages/génétique , Bactériophages/métabolisme , Chlorures/pharmacologie , Interactions hôte-pathogène , Pectobacterium/pathogénicité , Maladies des plantes/microbiologie , Virulence , Composés du zinc/pharmacologie
18.
Viruses ; 12(11)2020 11 17.
Article de Anglais | MEDLINE | ID: mdl-33213034

RÉSUMÉ

To provide insights into phage-host interactions during winemaking, we assessed whether phenolic compounds modulate the phage predation of Oenococcus oeni. Centrifugal partition chromatography was used to fractionate the phenolic compounds of a model red wine. The ability of lytic oenophage OE33PA to kill its host was reduced in the presence of two collected fractions in which we identified five compounds. Three, namely, quercetin, myricetin and p-coumaric acid, significantly reduced the phage predation of O. oeni when provided as individual pure molecules, as also did other structurally related compounds such as cinnamic acid. Their presence was correlated with a reduced adsorption rate of phage OE33PA on its host. Strikingly, none of the identified compounds affected the killing activity of the distantly related lytic phage Vinitor162. OE33PA and Vinitor162 were shown to exhibit different entry mechanisms to penetrate into bacterial cells. We propose that ligand-receptor interactions that mediate phage adsorption to the cell surface are diverse in O. oeni and are subject to differential interference by phenolic compounds. Their presence did not induce any modifications in the cell surface as visualized by TEM. Interestingly, docking analyses suggest that quercetin and cinnamic acid may interact with the tail of OE33PA and compete with host recognition.


Sujet(s)
Bactériophages/effets des médicaments et des substances chimiques , Oenococcus/virologie , Phénols/pharmacologie , Vin/analyse , Acides coumariques/composition chimique , Flavonoïdes/composition chimique , Interactions hôte-pathogène/effets des médicaments et des substances chimiques , Simulation de docking moléculaire , Oenococcus/effets des médicaments et des substances chimiques , Phénols/composition chimique
19.
PLoS Biol ; 18(10): e3000877, 2020 10.
Article de Anglais | MEDLINE | ID: mdl-33048924

RÉSUMÉ

Bacteriophages (phages) are critical players in the dynamics and function of microbial communities and drive processes as diverse as global biogeochemical cycles and human health. Phages tend to be predators finely tuned to attack specific hosts, even down to the strain level, which in turn defend themselves using an array of mechanisms. However, to date, efforts to rapidly and comprehensively identify bacterial host factors important in phage infection and resistance have yet to be fully realized. Here, we globally map the host genetic determinants involved in resistance to 14 phylogenetically diverse double-stranded DNA phages using two model Escherichia coli strains (K-12 and BL21) with known sequence divergence to demonstrate strain-specific differences. Using genome-wide loss-of-function and gain-of-function genetic technologies, we are able to confirm previously described phage receptors as well as uncover a number of previously unknown host factors that confer resistance to one or more of these phages. We uncover differences in resistance factors that strongly align with the susceptibility of K-12 and BL21 to specific phage. We also identify both phage-specific mechanisms, such as the unexpected role of cyclic-di-GMP in host sensitivity to phage N4, and more generic defenses, such as the overproduction of colanic acid capsular polysaccharide that defends against a wide array of phages. Our results indicate that host responses to phages can occur via diverse cellular mechanisms. Our systematic and high-throughput genetic workflow to characterize phage-host interaction determinants can be extended to diverse bacteria to generate datasets that allow predictive models of how phage-mediated selection will shape bacterial phenotype and evolution. The results of this study and future efforts to map the phage resistance landscape will lead to new insights into the coevolution of hosts and their phage, which can ultimately be used to design better phage therapeutic treatments and tools for precision microbiome engineering.


Sujet(s)
Bactériophages/physiologie , Escherichia coli/virologie , Protéines bactériennes/génétique , Protéines bactériennes/métabolisme , Bactériophages/effets des médicaments et des substances chimiques , Voies de biosynthèse/effets des médicaments et des substances chimiques , Systèmes CRISPR-Cas/génétique , GMP cyclique/analogues et dérivés , GMP cyclique/pharmacologie , ADN/génétique , Régulation négative/effets des médicaments et des substances chimiques , Régulation négative/génétique , Escherichia coli/effets des médicaments et des substances chimiques , Escherichia coli/génétique , Régulation de l'expression des gènes bactériens/effets des médicaments et des substances chimiques , Gènes essentiels , Génome bactérien , Mutation/génétique , Phénotype , Reproductibilité des résultats , Suppression génétique
20.
Nucleic Acids Res ; 48(18): 10383-10396, 2020 10 09.
Article de Anglais | MEDLINE | ID: mdl-32941607

RÉSUMÉ

In the constant evolutionary battle against mobile genetic elements (MGEs), bacteria have developed several defense mechanisms, some of which target the incoming, foreign nucleic acids e.g. restriction-modification (R-M) or CRISPR-Cas systems. Some of these MGEs, including bacteriophages, have in turn evolved different strategies to evade these hurdles. It was recently shown that the siphophage CAjan and 180 other viruses use 7-deazaguanine modifications in their DNA to evade bacterial R-M systems. Among others, phage CAjan genome contains a gene coding for a DNA-modifying homolog of a tRNA-deazapurine modification enzyme, together with four 7-cyano-7-deazaguanine synthesis genes. Using the CRISPR-Cas9 genome editing tool combined with the Nanopore Sequencing (ONT) we showed that the 7-deazaguanine modification in the CAjan genome is dependent on phage-encoded genes. The modification is also site-specific and is found mainly in two separate DNA sequence contexts: GA and GGC. Homology modeling of the modifying enzyme DpdA provides insight into its probable DNA binding surface and general mode of DNA recognition.


Sujet(s)
Bactériophages/génétique , ADN/génétique , Motifs nucléotidiques/génétique , Pyrimidinones/pharmacologie , Pyrroles/pharmacologie , Bactériophages/effets des médicaments et des substances chimiques , Séquence nucléotidique/effets des médicaments et des substances chimiques , Systèmes CRISPR-Cas/génétique , ADN/effets des médicaments et des substances chimiques , Enzymes de restriction-modification de l'ADN/effets des médicaments et des substances chimiques , Escherichia coli/virologie , Édition de gène , Guanine/analogues et dérivés , Guanine/pharmacologie , Humains , Séquençage par nanopores , Motifs nucléotidiques/effets des médicaments et des substances chimiques , Siphoviridae/génétique
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE